Search Within

Department of Medicine

Formats
  1. Journal Article (19593)
  2. Meeting Abstract (16038)
  3. Review (1150)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22321)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10646)
  5. Survivorship Research (9330)
  6. Division of Subspecialty Medicine (7535)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1071)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2111)

More Publishers

Results (39622)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety of tabelecleucel with pembrolizumab in recurrent/metastatic Epstein-Barr virus-associated nasopharyngeal carcinoma
    Meeting Abstract

    Colevas, A. D.; Cohen, R. B.; Park, J. C.; Pfister, D. G.; Massarelli, E.; Li, Z.; Xing, B.; Dinavahi, R.; Mehta, A.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • MagnetisMM-30: A phase 1b, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM)
    Meeting Abstract

    Lesokhin, A. M.; Raza, M. S.; Acosta, J.; Muller, P.; O'Connell, A.; Yver, A.; Lou, C.; Finn, G.; Service, M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Preliminary results from FLAGSHP-1: A phase 1 study of ERAS-601 as a monotherapy or in combination with cetuximab in patients (pts) previously treated for advanced chordoma
    Meeting Abstract

    Gounder, M. M.; Rosen, E.; Parikh, A. R.; Conley, A. P.; Hong, D. S.; Sheth, S.; Mai, N.; Sgroe, E.; Mitchell, R.; Picard, R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase 2 study evaluating selinexor monotherapy in patients with JAKi-naive myelofibrosis and moderate thrombocytopenia
    Meeting Abstract

    Scandura, J.; Gerds, A. T.; Ritchie, E. K.; Wang, X. L.; Kye, S.; Rampal, R.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • HOPE: Harnessing olaparib, palbociclib, and endocrine therapy for BRCA1/2-associated HR+, HER2- metastatic breast cancer
    Meeting Abstract

    Shah, P. D.; Torres, A.; Aaron, M.; Narayan, V.; Knollman, H. M.; Bradbury, A. R.; DeMichele, A.; Robson, M. E.; Tung, N. M.; Domchek, S. M.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Phase I/II first-in-human study to evaluate the safety and efficacy of tissue factor-ADC MRG004A in patients with solid tumors
    Meeting Abstract

    Park, W.; Zhang, J.; Dayyani, F.; Shan, J.; Liu, R.; Guo, R.; O'Reilly, E. M.; Liu, Z.; Gao, S.; Wu, X.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib in the United States
    Meeting Abstract

    Marrone, M.; Geller, R.; Oladapo, A.; Suthar, P.; Vasudevan, A.; Vredenburg, M.; Zeng, J.; Rampal, R.; Mascarenhas, J.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Multidimensional analysis of B7 homolog 3 (B7-H3) RNA expression in small-cell lung cancer (SCLC) molecular subtypes
    Meeting Abstract

    Gay, C. M.; Owonikoko, T. K.; Byers, L. A.; Choudhury, N. J.; Ahmed, S.; Cain, Z.; Qian, X. Z.; Brentnall, M.; Heeke, S.; Poi, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Impact of trial eligibility criteria on enrollment to KRAS(G12C) inhibitor trials in patients with non-small cell lung cancer
    Meeting Abstract

    May, M. S.; Wooster, M.; May, B.; Shu, C. A.; Henick, B. S.; Stoopler, M.; Smith-Marrone, S.; Saqi, A.; Mansukhani, M. M.; Riely, G. J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Efficacy of treatment with traditional Chinese patent medicine (Fufang E'jiao Syrup) for cancer-related fatigue in patients with advanced cancer: A randomized, double-blinded, placebo-controlled, multicenter trial
    Meeting Abstract

    Gu, S. S.; Xu, Y.; Mao, J. J.; Sun, L.; Cui, N.; Wang, F.; Dong, J.; Guo, X.; Fu, L.; Wang, J.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save